ClinicalTrials.Veeva

Menu

mHealth Intervention for Pain Self Management (PsyMINT)

Virginia Commonwealth University (VCU) logo

Virginia Commonwealth University (VCU)

Status

Not yet enrolling

Conditions

Cancer Survivorship
Symptom Management
Pain Management
Pain
Symptom Monitoring

Treatments

Behavioral: Mobile Health (mHealth) Intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07332377
P50MD017319 (U.S. NIH Grant/Contract)
MCC-25-22625
HM300000094 (Other Identifier)

Details and patient eligibility

About

This is a feasibility pilot test of a single-arm intervention to evaluate the beta version of an mHealth app-based behavioral intervention prior to scaling for a randomized controlled trial (RCT). This mHealth intervention is designed to enhance self-efficacy and support pain and symptom self-management among post-treatment cancer survivors.

Full description

The intervention involves a set of tested intervention messages, ecological momentary assessments (EMAs), and e-diary entries to our PsyMINT mobile app. A 1-week mHealth intervention to cancer survivors who experience pain will be delivered. The feasibility of an mHealth app platform (PsyMINT) as a message presentation environment will be delivered and evaluated. The app messages will target five topics/modules, including psychoeducational materials related to pain management; positive psychology; opioid literacy; skill building for patient-provider communication and trust; and quality of life.

Enrollment

25 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • In a post-treatment stage with no evidence of disease (complete remission)
  • Diagnosed with cancer in the past three years
  • Experiencing cancer/treatment-related pain
  • ≥ 18 years of age at the time of first diagnosis
  • Cognitively able to actively participate in an online-based study
  • Able to read, write, and understand English

Exclusion criteria

  • Individuals who currently use any medication for psychiatric reasons (including stimulants, and mood stabilizers)
  • Patients with major psychotic disorders (bipolar disorder or schizophrenia) and/or substance use disorders.
  • Those who are currently pregnant or plan to become pregnant in the next three months

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 1 patient group

Mobile Health (mHealth) Intervention
Experimental group
Description:
Implement a bank of 60 mHealth intervention messages, ecological momentary assessments (EMAs), and e-diary entries to PiLR to deliver a 1-week mHealth intervention to cancer survivors experiencing pain
Treatment:
Behavioral: Mobile Health (mHealth) Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Sun Jung Kim, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems